Skip to Content

TEVA B1 (Letrozole 2.5 mg)

Pill imprint TEVA B1 has been identified as Letrozole 2.5 mg.

Letrozole is used in the treatment of female infertility; breast cancer, metastatic; breast cancer, adjuvant; breast cancer and belongs to the drug classes aromatase inhibitors, hormones/antineoplastics. There is positive evidence of human fetal risk during pregnancy. Letrozole 2.5 mg is not a controlled substance under the Controlled Substance Act (CSA).

Letrozole 2.5 mg TEVA B1
Letrozole 2.5 mg TEVA B1
Letrozole 2.5 mg TEVA B1
Letrozole
Imprint:
TEVA B1
Strength:
2.5 mg
Color:
Yellow
Shape:
Round
Availability:
Prescription only
Drug Class:
Aromatase inhibitors
Hormones/antineoplastics
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
Not a controlled drug
Manufacturer:
Teva Pharmaceuticals USA Inc
National Drug Code (NDC):
00093-7620
Inactive Ingredients:
silicon dioxide
FD&C Blue No. 2
aluminum oxide
FD&C Yellow No. 5
ferric oxide yellow
lactose monohydrate
magnesium stearate
microcrystalline cellulose
polyethylene glycol
polyvinyl alcohol
sodium starch glycolate type A potato
corn starch
magnesium silicate
titanium dioxide
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
42291-0374 AvKare, Inc.

Note: Inactive ingredients may vary.

View Details Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide